Compare PFE & BBVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | BBVA |
|---|---|---|
| Founded | 1849 | 1857 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 117.0B |
| IPO Year | N/A | N/A |
| Metric | PFE | BBVA |
|---|---|---|
| Price | $25.73 | $22.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $28.30 | N/A |
| AVG Volume (30 Days) | ★ 57.7M | 1.3M |
| Earning Date | 11-04-2025 | 01-29-2026 |
| Dividend Yield | ★ 6.67% | 3.00% |
| EPS Growth | ★ 131.89 | 7.95 |
| EPS | 1.73 | ★ 2.04 |
| Revenue | ★ $62,785,000,000.00 | $37,116,038,958.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $4.72 |
| P/E Ratio | $14.93 | ★ $10.82 |
| Revenue Growth | 3.89 | ★ 6.03 |
| 52 Week Low | $20.92 | $9.44 |
| 52 Week High | $27.69 | $22.37 |
| Indicator | PFE | BBVA |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 68.04 |
| Support Level | $25.13 | $21.65 |
| Resistance Level | $26.19 | $22.24 |
| Average True Range (ATR) | 0.54 | 0.30 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 77.75 | 98.85 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Despite its Spanish origins, Banco Bilbao Vizcaya Argentaria generates only around one-fourth of its profits in Spain. We expect that on a normalized basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.